Caribou Biosciences, Inc.

CRBU · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$16,293$51,162$58,338$240,420
Short-Term Investments$193,244$277,665$189,325$135,412
Receivables$3,251$3,859$4,664$8,124
Inventory$0$0$0$0
Other Curr. Assets$6,589$6,155$7,921$7,236
Total Curr. Assets$219,377$338,841$260,248$391,192
Property Plant & Equip (Net)$39,290$40,452$34,908$4,887
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$49,125$51,330$77,071$45,302
Tax Assets$0$0$0$0
Other NC Assets$5,521$1,586$1,538$975
Total NC Assets$93,936$93,368$113,517$51,164
Other Assets$0$0$0$0
Total Assets$313,313$432,209$373,765$442,356
Liabilities
Payables$2,476$3,120$1,146$3,990
Short-Term Debt$1,426$1,200$966$259
Tax Payable$0$0$0$0
Deferred Revenue$3,129$2,847$9,937$8,703
Other Curr. Liab.$23,620$21,135$16,079$12,877
Total Curr. Liab.$30,651$28,302$28,128$25,829
LT Debt$25,061$25,908$26,780$0
Deferred Rev, NC$3,317$6,102$15,954$22,032
Deferred Tax Liab, NC$548$557$381$476
Other NC Liab.$785$2,939$1,651$6,194
Total NC Liab.$29,711$35,506$44,766$28,702
Other Liabilities$0$0$0$0
Cap. Leases$26,487$27,108$27,746$0
Total Liabilities$60,362$63,808$72,894$54,531
Equity
Pref Stock$0$0$0$0
Common Stock$9$8$6$6
Retained Earnings-$448,390-$299,285-$197,215-$97,794
AOCI$255$30-$1,518-$135
Other Equity$701,077$667,648$499,598$485,748
Total Equity$252,951$368,401$300,871$387,825
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$313,313$432,209$373,765$442,356
Net Debt$10,194-$24,054-$30,592-$240,161
Caribou Biosciences, Inc. (CRBU) Financial Statements & Key Stats | AlphaPilot